World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
21893
World Ranking
17602
National Ranking
585

Overview

Peter S. Macdonald is affiliated with the Victor Chang Cardiac Research Institute in Australia. Their research spans a broad spectrum within medicine, with a focus on transplantation and cardiovascular fields.

The scientist has a substantial publication record, with notable contributions in several specialized areas including surgery, cardiology and cardiovascular medicine, biomedical engineering, transplantation, and pulmonary and respiratory medicine.

Key topics covered in their work include:

  • Transplantation: Methods and Outcomes
  • Mechanical Circulatory Support Devices
  • Organ Transplantation Techniques and Outcomes
  • Renal Transplantation Outcomes and Treatments
  • Cardiac Structural Anomalies and Repair
  • Viral Infections and Immunology Research
  • Heart Failure Treatment and Management

Their recent significant papers illustrate a range of clinical and translational research interests. Among these are:

  • "Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure," 2020, published in New England Journal of Medicine
  • "Donor heart and lung procurement: A consensus statement," 2020, published in The Journal of Heart and Lung Transplantation
  • "Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial," 2022, published in The Lancet
  • "Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure," 2021, published in JAMA Cardiology
  • "The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support," 2023, published in The Journal of Heart and Lung Transplantation

The primary venues for their publications include:

  • The Journal of Heart and Lung Transplantation
  • Heart Lung and Circulation
  • Transplantation
  • JHLT Open
  • Journal of Cardiac Failure

Peter S. Macdonald frequently collaborates with a core group of co-authors who have contributed substantially to their body of work. These collaborators include:

  • K. Muthiah
  • P. Jansz
  • Chris Hayward
  • Andrew Jabbour
  • S. Scheuer

The scientist's research contributions predominantly cover clinical and practical aspects of transplantation medicine and cardiovascular disease management, addressing both surgical methods and device-based therapies. Their work incorporates clinical trials and consensus statements that support guidelines and standards within the heart and lung transplant community.

Best Publications

  • Report from a consensus conference on primary graft dysfunction after cardiac transplantation.

    Jon Kobashigawa;Andreas Zuckermann;Peter Macdonald;Pascal Leprince

  • Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 Years A Randomized Clinical Trial

    Anne Keogh;Meroula Richardson;Peter Ruygrok;Phillip Spratt

  • Myocardial infarction increases ACE2 expression in rat and humans.

    Louise M. Burrell;John Risvanis;Eiji Kubota;Rachael G. Dean

  • Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

    John R. Teerlink;Rafael Diaz;G. Michael Felker;John J.V. McMurray

  • Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease

    Angharad M. Roberts;Angharad M. Roberts;James S. Ware;Daniel S. Herman;Daniel S. Herman;Daniel S. Herman;Sebastian Schafer

  • Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series

    Kumud Dhital;Arjun Iyer;Arjun Iyer;Mark Connellan;Hong Chee Chew;Hong Chee Chew

  • Mutations in Cardiac T-Box Factor Gene TBX20 Are Associated with Diverse Cardiac Pathologies, Including Defects of Septation and Valvulogenesis and Cardiomyopathy

    Edwin P. Kirk;Edwin P. Kirk;Edwin P. Kirk;Margaret Sunde;Mauro W. Costa;Mauro W. Costa;Scott A Rankin

  • Right ventricular diastolic impairment in patients with pulmonary arterial hypertension

    Silvia Rain;M Louis Handoko;Pia Trip;C Tji-Joong Gan

  • Increased nitric oxide production in heart failure

    Winlaw Ds;Smythe Ga;Keogh Am;Schyvens Cg

  • National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018

    John J Atherton;Andrew Sindone;Carmine Gerardo De Pasquale;Andrea Driscoll

  • Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension.

    Olivier Sitbon;Virginie Gressin;Rudolf Speich;Peter S. Macdonald

  • Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

    John R. Teerlink;John R. Teerlink;G. Michael Felker;John J. V. McMurray;Scott D. Solomon

  • Pregnancy outcomes in pulmonary arterial hypertension in the modern management era

    Xavier Jaïs;Karen M. Olsson;Joan A. Barbera;Isabel Blanco

  • Skin cancer in Australian heart transplant recipients

    Colin S. Ong;Anne M. Keogh;Steven Kossard;Peter S. Macdonald

  • Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience.

    Michael J. Veness;David I. Quinn;Colin S. Ong;Anne M. Keogh

  • Parenteral administration of recombinant human neuregulin‐1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses

    Andrew Jabbour;Andrew Jabbour;Christopher S. Hayward;Anne M. Keogh;Anne M. Keogh;Eugene Kotlyar

  • Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells.

    M. Kubota;J.M. Moseley;L. Butera;G.J. Dusting

  • Hemodynamic Effects of Bosentan, an Endothelin Receptor Antagonist, in Patients With Pulmonary Hypertension

    D J Williamson;L L Wallman;R Jones;A M Keogh

  • Differences Between Beta-Blockers in Patients With Chronic Heart Failure and Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial

    Andrew Jabbour;Peter S. Macdonald;Peter S. Macdonald;Peter S. Macdonald;Anne M. Keogh;Anne M. Keogh;Anne M. Keogh;Eugene Kotlyar

  • Outcomes of Donation After Circulatory Death Heart Transplantation in Australia.

    Hong Chee Chew;Arjun Iyer;Mark Connellan;Sarah Scheuer

Frequent Co-Authors

Anne Keogh
Anne Keogh University of New South Wales
Patricia M. Davidson
Patricia M. Davidson Johns Hopkins University
Robert M. Graham
Robert M. Graham Victor Chang Cardiac Research Institute
Henry Krum
Henry Krum Monash University
Kay Wilhelm
Kay Wilhelm University of Notre Dame
Simon Stewart
Simon Stewart Torrens University Australia
John D. Horowitz
John D. Horowitz University of Adelaide
Richard P. Harvey
Richard P. Harvey Victor Chang Cardiac Research Institute
Jon A. Kobashigawa
Jon A. Kobashigawa Cedars-Sinai Medical Center
Daniel Kim
Daniel Kim Northeastern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Looking to pursue a career in the medical field, but unsure if medical school is the right fit? There are many related online degrees and entry pathways that can complement or provide alternatives to a traditional MD.

For those interested in nursing, consider direct entry msn programs online. These programs are designed for non-nurses and can fast-track your transition into advanced nursing roles. If you are seeking the most accessible routes, research the easiest bsn program to get into to begin your journey as an RN quickly.

Beyond nursing, medical billing and coding offers promising remote job prospects. There are top-rated schools offering financial aid for medical billing and coding online classes, making this pathway both affordable and viable.

Lastly, some nursing programs offer an alternative admission process that may not require the standardized TEAS or HESI exams. If testing is a concern, find out: do i need to take the teas test for lpn. Explore these options to chart a rewarding healthcare career tailored to your interests and needs.

Best Scientists Citing Peter S. Macdonald

Trending Scientists